BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19512850)

  • 21. Magnetic resonance imaging of the prostate.
    Iversen P; Kjaer L; Thomsen C; Henriksen O
    Scand J Urol Nephrol Suppl; 1987; 104():41-5. PubMed ID: 3481468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR staging of prostate cancer. How we can improve our accuracy with decisions aids and optimal techniques.
    Tempany CM
    Magn Reson Imaging Clin N Am; 1996 Aug; 4(3):519-32. PubMed ID: 8873017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.
    McMahon CJ; Bloch BN; Lenkinski RE; Rofsky NM
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):363-83. PubMed ID: 19406364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer: multiparametric MR imaging for detection, localization, and staging.
    Hoeks CM; Barentsz JO; Hambrock T; Yakar D; Somford DM; Heijmink SW; Scheenen TW; Vos PC; Huisman H; van Oort IM; Witjes JA; Heerschap A; Fütterer JJ
    Radiology; 2011 Oct; 261(1):46-66. PubMed ID: 21931141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance imaging in breast cancer.
    Van Goethem M; Tjalma W; Schelfout K; Verslegers I; Biltjes I; Parizel P
    Eur J Surg Oncol; 2006 Nov; 32(9):901-10. PubMed ID: 16920327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current role of MR imaging in the staging of adenocarcinoma of the prostate.
    Schiebler ML; Schnall MD; Pollack HM; Lenkinski RE; Tomaszewski JE; Wein AJ; Whittington R; Rauschning W; Kressel HY
    Radiology; 1993 Nov; 189(2):339-52. PubMed ID: 8210358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-Tesla high-resolution MR imaging of the wrist.
    Saupe N
    Semin Musculoskelet Radiol; 2009 Mar; 13(1):29-38. PubMed ID: 19235670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution MRI of the human parotid gland and duct at 7 Tesla.
    Kraff O; Theysohn JM; Maderwald S; Kokulinsky PC; Dogan Z; Kerem A; Kruszona S; Ladd ME; Gizewski ER; Ladd SC
    Invest Radiol; 2009 Sep; 44(9):518-24. PubMed ID: 19652615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal magnetic resonance imaging at 3 T: oncological applications.
    Marin D; Husarik DB; Boll DT; Merkle EM
    Top Magn Reson Imaging; 2010 Jun; 21(3):149-56. PubMed ID: 21847034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
    Macura KJ
    Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
    [No Abstract]   [Full Text] [Related]  

  • 31. Diffusion and perfusion MR imaging of the prostate.
    Somford DM; Fütterer JJ; Hambrock T; Barentsz JO
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):685-95, ix. PubMed ID: 18926431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Magnetic resonance imaging and prostate cancer].
    Cornud F; Villers A; Mongiat-Artus P; Rebillard X; Soulie M;
    Prog Urol; 2008 Nov; 18(10):621-33. PubMed ID: 18971104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton spectroscopic and dynamic contrast-enhanced magnetic resonance: a modern approach in prostate cancer imaging.
    Sciarra A; Salciccia S; Panebianco V
    Eur Urol; 2008 Sep; 54(3):485-8. PubMed ID: 18439748
    [No Abstract]   [Full Text] [Related]  

  • 34. Prostate cancer: a review of common underwriting problems, part 2.
    Richie RC; Swanson JO
    J Insur Med; 2004; 36(4):310-9. PubMed ID: 15683209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
    Fuchsjäger M; Akin O; Shukla-Dave A; Pucar D; Hricak H
    Clin Adv Hematol Oncol; 2009 Mar; 7(3):193-202. PubMed ID: 19398944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-T MRI with phased-array coil in local staging of prostatic cancer.
    Torricelli P; Barberini A; Cinquantini F; Sighinolfi M; Cesinaro AM
    Acad Radiol; 2008 Sep; 15(9):1118-25. PubMed ID: 18692752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate MR imaging at high-field strength: evolution or revolution?
    Rouvière O; Hartman RP; Lyonnet D
    Eur Radiol; 2006 Feb; 16(2):276-84. PubMed ID: 16155721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of low-field strength magnetic resonance imaging in bladder cancer staging].
    Lutsenko PE; Bulanova TV; Chernyshev IV; Churaiants VV
    Vestn Rentgenol Radiol; 2007; (2):46-51. PubMed ID: 18380198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance.
    Villers A; Lemaitre L; Haffner J; Puech P
    Curr Opin Urol; 2009 May; 19(3):274-82. PubMed ID: 19325494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advancements in magnetic resonance imaging of the prostate.
    Macura KJ
    Top Magn Reson Imaging; 2008 Dec; 19(6):259-60. PubMed ID: 19512847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.